NO323107B1 - Anvendelse av fotosensibiliseringsmiddel for fremstilling av medikament for anvendelse i behandling for a odelegge eller skade et omrade av neovaskularisering - Google Patents

Anvendelse av fotosensibiliseringsmiddel for fremstilling av medikament for anvendelse i behandling for a odelegge eller skade et omrade av neovaskularisering Download PDF

Info

Publication number
NO323107B1
NO323107B1 NO19952004A NO952004A NO323107B1 NO 323107 B1 NO323107 B1 NO 323107B1 NO 19952004 A NO19952004 A NO 19952004A NO 952004 A NO952004 A NO 952004A NO 323107 B1 NO323107 B1 NO 323107B1
Authority
NO
Norway
Prior art keywords
light
photosensitizer
treatment
bpd
animal
Prior art date
Application number
NO19952004A
Other languages
English (en)
Norwegian (no)
Other versions
NO952004L (no
NO952004D0 (no
Inventor
Julia G Levy
Anna M Richter
Elizabeth Waterfield
Original Assignee
Univ British Columbia
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ British Columbia filed Critical Univ British Columbia
Publication of NO952004D0 publication Critical patent/NO952004D0/no
Publication of NO952004L publication Critical patent/NO952004L/no
Publication of NO323107B1 publication Critical patent/NO323107B1/no

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61NELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N5/00Radiation therapy
    • A61N5/06Radiation therapy using light
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61NELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N5/00Radiation therapy
    • A61N5/06Radiation therapy using light
    • A61N5/0613Apparatus adapted for a specific treatment
    • A61N5/062Photodynamic therapy, i.e. excitation of an agent
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/0057Photodynamic therapy with a photosensitizer, i.e. agent able to produce reactive oxygen species upon exposure to light or radiation, e.g. UV or visible light; photocleavage of nucleic acids with an agent
    • A61K41/0071PDT with porphyrins having exactly 20 ring atoms, i.e. based on the non-expanded tetrapyrrolic ring system, e.g. bacteriochlorin, chlorin-e6, or phthalocyanines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pathology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Radiology & Medical Imaging (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Photoreceptors In Electrophotography (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Indole Compounds (AREA)
  • Radiation-Therapy Devices (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Adhesives Or Adhesive Processes (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicinal Preparation (AREA)
NO19952004A 1992-11-20 1995-05-19 Anvendelse av fotosensibiliseringsmiddel for fremstilling av medikament for anvendelse i behandling for a odelegge eller skade et omrade av neovaskularisering NO323107B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US97954692A 1992-11-20 1992-11-20
PCT/CA1993/000490 WO1994012239A1 (en) 1992-11-20 1993-11-17 Method of activating photosensitive agents

Publications (3)

Publication Number Publication Date
NO952004D0 NO952004D0 (no) 1995-05-19
NO952004L NO952004L (no) 1995-07-11
NO323107B1 true NO323107B1 (no) 2007-01-02

Family

ID=25526957

Family Applications (1)

Application Number Title Priority Date Filing Date
NO19952004A NO323107B1 (no) 1992-11-20 1995-05-19 Anvendelse av fotosensibiliseringsmiddel for fremstilling av medikament for anvendelse i behandling for a odelegge eller skade et omrade av neovaskularisering

Country Status (20)

Country Link
US (2) US5705518A (de)
EP (2) EP0947222B1 (de)
JP (1) JP3146008B2 (de)
KR (1) KR100230588B1 (de)
AT (2) ATE189966T1 (de)
AU (1) AU679016B2 (de)
CA (1) CA2149636C (de)
DE (3) DE69327972T2 (de)
DK (2) DK0680365T3 (de)
ES (2) ES2143539T3 (de)
FI (1) FI952436A7 (de)
GR (1) GR3033362T3 (de)
HU (1) HU224722B1 (de)
IL (1) IL107676A (de)
NO (1) NO323107B1 (de)
PH (1) PH31688A (de)
PL (1) PL172480B1 (de)
PT (2) PT947222E (de)
WO (1) WO1994012239A1 (de)
ZA (1) ZA938710B (de)

Families Citing this family (50)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6710066B2 (en) * 1989-07-28 2004-03-23 Queen's University At Kingston Photochemotherapeutic method using 5-aminolevulinic acid and other precursors of endogenous porphyrins
US20020058008A1 (en) * 1989-07-28 2002-05-16 Kennedy James C. Photochemotherapeutic method using 5-aminolevulinic acid and other precursors of endogenous porphyrins
US20040110819A1 (en) * 1991-10-28 2004-06-10 Queen's University At Kingston Photochemotherapeutic method using 5-aminolevulinic acid and other precursors of endogenous porphyrins
US6890555B1 (en) * 1992-02-05 2005-05-10 Qlt, Inc. Liposome compositions of porphyrin photosensitizers
US5368841A (en) * 1993-02-11 1994-11-29 The General Hospital Corporation Photodynamic therapy for the destruction of the synovium in the treatment of rheumatoid arthritis and the inflammatory arthritides
JP3565442B2 (ja) * 1993-04-22 2004-09-15 新日本石油化学株式会社 哺乳類の関節炎の診断剤および/または治療剤
US5798349A (en) 1994-03-14 1998-08-25 The General Hospital Corporation Use of green porphyrins to treat neovasculature in the eye
JP2961074B2 (ja) 1995-09-06 1999-10-12 明治製菓株式会社 光化学療法用の新生血管閉塞剤
EP0881874B1 (de) * 1995-11-06 2003-04-02 New York Blood Center, Inc. Behandlung von roten blutzellen zur inaktivierung von virien durch verwendung von pathalocyanine und rotlicht
JP3845469B2 (ja) 1996-02-21 2006-11-15 明治製菓株式会社 眼底の新生血管の閉塞に用いる投与剤
GB9700396D0 (en) * 1997-01-10 1997-02-26 Photocure As Photochemotherapeutic compositions
US6008889A (en) * 1997-04-16 1999-12-28 Zeng; Haishan Spectrometer system for diagnosis of skin disease
US6103706A (en) * 1997-04-29 2000-08-15 New York Blood Center, Inc. Methods for treating viral infections
US6010890A (en) * 1997-04-29 2000-01-04 New York Blood Center, Inc. Method for viral inactivation and compositions for use in same
DE19721489A1 (de) * 1997-05-23 1998-11-26 Tibor Dr Nagypal System zur photodynamischen Behandlung von Lebewesen, deren Organen und/oder Geweben
US6128525A (en) * 1997-07-29 2000-10-03 Zeng; Haishan Apparatus and method to monitor photodynamic therapy (PDT)
US6096066A (en) * 1998-09-11 2000-08-01 Light Sciences Limited Partnership Conformal patch for administering light therapy to subcutaneous tumors
US6117862A (en) 1998-10-09 2000-09-12 Qlt, Inc. Model and method for angiogenesis inhibition
IL126953A0 (en) 1998-11-08 1999-09-22 Yeda Res & Dev Pharmaceutical compositions comprising porphyrins and some novel porphyrin derivatives
US6454789B1 (en) * 1999-01-15 2002-09-24 Light Science Corporation Patient portable device for photodynamic therapy
EP1131099A2 (de) * 1999-01-15 2001-09-12 Light Sciences Corporation Nichtinvasiven vaskulären therapie
US6602274B1 (en) 1999-01-15 2003-08-05 Light Sciences Corporation Targeted transcutaneous cancer therapy
ATE234114T1 (de) * 1999-01-15 2003-03-15 Light Sciences Corp Therapeutische zusammensetzungen fur knochenstoffwechselstörungen oder knochenmetastasen enthaltend einen photosensitizer und ein bisphosphonat
US20020022032A1 (en) * 1999-04-23 2002-02-21 Curry Patrick Mark Immuno-adjuvant PDT treatment of metastatic tumors
US20030114434A1 (en) * 1999-08-31 2003-06-19 James Chen Extended duration light activated cancer therapy
ATE309807T1 (de) * 1999-09-24 2005-12-15 Vasogen Ireland Ltd Zusammensetzung zur behandlung von atherosklerose,welche ein statin und ex-vivo behandeltes blut enthält
US7897140B2 (en) 1999-12-23 2011-03-01 Health Research, Inc. Multi DTPA conjugated tetrapyrollic compounds for phototherapeutic contrast agents
CA2395567A1 (en) * 2000-01-12 2001-07-19 Light Sciences Corporation Novel treatment for eye disease
JP2003528926A (ja) * 2000-03-24 2003-09-30 ノバルティス アクチエンゲゼルシャフト 新血管形成の改善された処置
US6454790B1 (en) * 2000-07-21 2002-09-24 Ceramoptec Industries, Inc. Treatment for Barrett's syndrome
WO2002019594A2 (en) * 2000-08-02 2002-03-07 Arizona Board Of Regents, Acting On Behalf Of Arizona State University Scanning fluorescence lifetime microscope: directed evolution
RU2195346C2 (ru) * 2001-03-15 2002-12-27 9 Лечебно-диагностический центр Министерства Обороны Российской Федерации Аппарат лазерного облучения крови
US20030125314A1 (en) * 2001-12-03 2003-07-03 Edie Zusman Photodynamic therapy for the treatment of epilepsy
DE10162712A1 (de) * 2001-12-19 2003-07-17 Blutspendienst Der Landesverba Verfahren zur Inaktivierung von Bakterien und Leukozyten in Blut oder Blutprodukten
CA2473924A1 (en) * 2002-01-23 2003-07-31 Light Sciences Corporation Systems and methods for photodynamic therapy
US7041121B1 (en) * 2002-01-31 2006-05-09 Medtronicvidamed, Inc. Apparatus for treating prostate cancer and method for same
AU2003248747A1 (en) 2002-06-27 2004-01-19 Health Research, Inc. Fluorinated chlorin and bacteriochlorin photosensitizers for photodynamic therapy
WO2004005289A2 (en) 2002-07-02 2004-01-15 Health Research, Inc. Efficient synthesis of pyropheophorbide a and its derivatives
WO2004030588A2 (en) * 2002-10-03 2004-04-15 Light Sciences Corporation Excitation of photoreactive compounds in eye tissue
US7780992B2 (en) * 2002-12-08 2010-08-24 Tareq Abduljalil Albahri Antiviral medicament
RU2248231C2 (ru) * 2003-03-05 2005-03-20 9 Лечебно-диагностический центр Министерства Обороны Российской Федерации Аппарат лазерного облучения крови
US20040220167A1 (en) * 2003-05-02 2004-11-04 Nasrollah Samiy Methods of treating neuralgic pain
US20060020033A1 (en) * 2004-07-21 2006-01-26 Ali Moiin Method for treating dermatological viral infections
WO2007130465A2 (en) * 2006-05-02 2007-11-15 Green Medical, Inc. Systems and methods for treating superficial venous malformations like spider veins
US7465312B2 (en) * 2006-05-02 2008-12-16 Green Medical, Inc. Systems and methods for treating superficial venous malformations like spider veins
WO2011059216A2 (ko) * 2009-11-10 2011-05-19 가톨릭대학교 산학협력단 광감작제가 코팅된 의료용 스텐트 및 이의 제조방법
KR101200210B1 (ko) * 2009-11-10 2012-11-09 가톨릭대학교 산학협력단 광감작제가 코팅된 의료용 스텐트 및 이의 제조방법
US9211214B2 (en) 2012-03-21 2015-12-15 Valeant Pharmaceuticals International, Inc Photodynamic therapy laser
GB2517707B (en) 2013-08-28 2020-09-02 Pci Biotech As A device for light-induced rupture of endocytic vesicles to effect the delivery of an antigen
CN106620893B (zh) 2015-07-23 2021-07-30 爱博诺德(北京)医疗科技股份有限公司 用于眼部疾病光治疗的材料

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4521762A (en) 1981-08-27 1985-06-04 Gte Automatic Electric Laboratories, Incorporated Integratable D/A converter
US4649151A (en) * 1982-09-27 1987-03-10 Health Research, Inc. Drugs comprising porphyrins
US4577636A (en) 1982-11-23 1986-03-25 The Beth Israel Hospital Association Method for diagnosis of atherosclerosis
DE3472810D1 (en) 1983-03-07 1988-08-25 Carcedo Jacinto Munoz Anchorage systems for partition panels
US4753958A (en) 1985-02-07 1988-06-28 University Of Cal Photochemotherapy of epithelial diseases with derivatives of hematoporphyrins
US5095030A (en) * 1987-01-20 1992-03-10 University Of British Columbia Wavelength-specific cytotoxic agents
US4878891A (en) 1987-06-25 1989-11-07 Baylor Research Foundation Method for eradicating infectious biological contaminants in body tissues
US4957481A (en) * 1987-10-01 1990-09-18 U.S. Bioscience Photodynamic therapeutic technique
DE68929063T2 (de) 1988-02-01 2000-02-24 Matsushita Electric Industrial Co., Ltd. Dreidimensionale bildformungsanordnung
GB8805849D0 (en) * 1988-03-11 1988-04-13 Efamol Holdings Porphyrins & cancer treatment
US4925736A (en) 1988-07-06 1990-05-15 Long Island Jewish Medical Center Topical hematoporphyrin
US5028594A (en) * 1988-12-27 1991-07-02 Naxcor Use of photodynamic compositions for cytotoxic effects
US4935498A (en) 1989-03-06 1990-06-19 Board Of Regents, The University Of Texas System Expanded porphyrins: large porphyrin-like tripyrroledimethine-derived macrocycles
CA2012175A1 (en) * 1989-03-31 1990-09-30 Michael W. Berns Photochemical treatment of blood vessels
US4973848A (en) * 1989-07-28 1990-11-27 J. Mccaughan Laser apparatus for concurrent analysis and treatment
CH684166A5 (it) * 1990-09-28 1994-07-29 Teclas Tecnologie Laser S A Apparecchiatura dedicata a radiazione rossa per fotochemioterapia.
ES2160600T3 (es) * 1992-09-21 2001-11-16 Quadra Logic Tech Inc Activacion transcutanea in vivo de agentes fotosensibles en la sangre.

Also Published As

Publication number Publication date
FI952436L (fi) 1995-07-05
KR950704007A (ko) 1995-11-17
PT947222E (pt) 2006-09-29
JPH08505069A (ja) 1996-06-04
HUT72037A (en) 1996-03-28
DE69334009D1 (de) 2006-05-24
ES2148132T3 (es) 2006-12-01
US5770619A (en) 1998-06-23
FI952436A7 (fi) 1995-07-05
CA2149636C (en) 2001-04-03
NO952004L (no) 1995-07-11
HK1025059A1 (en) 2000-11-03
EP0680365A1 (de) 1995-11-08
DE69327972D1 (de) 2000-04-06
FI952436A0 (fi) 1995-05-19
IL107676A0 (en) 1994-02-27
ATE322932T1 (de) 2006-04-15
US5705518A (en) 1998-01-06
DE69334009T2 (de) 2006-11-23
IL107676A (en) 1999-11-30
DE947222T1 (de) 2000-05-04
GR3033362T3 (en) 2000-09-29
HU9501489D0 (en) 1995-07-28
WO1994012239A1 (en) 1994-06-09
CA2149636A1 (en) 1994-06-09
EP0947222B1 (de) 2006-04-12
DE69327972T2 (de) 2000-11-02
EP0947222A2 (de) 1999-10-06
EP0947222A3 (de) 1999-10-27
KR100230588B1 (ko) 1999-12-01
AU5460094A (en) 1994-06-22
NO952004D0 (no) 1995-05-19
DK0680365T3 (da) 2000-06-05
DK0947222T3 (da) 2006-09-04
ATE189966T1 (de) 2000-03-15
AU679016B2 (en) 1997-06-19
PH31688A (en) 1999-01-18
ZA938710B (en) 1994-06-30
ES2143539T3 (es) 2000-05-16
PL309033A1 (en) 1995-09-18
PL172480B1 (pl) 1997-09-30
JP3146008B2 (ja) 2001-03-12
ES2148132T1 (es) 2000-10-16
EP0680365B1 (de) 2000-03-01
HU224722B1 (en) 2006-01-30
PT680365E (pt) 2000-07-31

Similar Documents

Publication Publication Date Title
AU679016B2 (en) Method of activating photosensitive agents
CA2144327C (en) Transcutaneous in vivo activation of photosensitive agents in blood
Lui et al. Photodynamic therapy in dermatology: recent developments
Mellish et al. Verteporfin: a milestone in opthalmology and photodynamic therapy
Messmann et al. Enhancement of photodynamic therapy with 5-aminolaevulinic acid-induced porphyrin photosensitisation in normal rat colon by threshold and light fractionation studies
Fingar et al. Drug and light dose dependence of photodynamic therapy: a study of tumor and normal tissue response
Spikes et al. Photodynamic therapy of tumours and other diseases using porphyrins
Kinsella et al. Photodynamic therapy in oncology
Gomer et al. Molecular, cellular, and tissue responses following photodynamic therapy
US20040147501A1 (en) Photodynamic therapy
KR20060126470A (ko) 국소 지방 세포 감소용 광선역학 치료법
Sharma et al. Mechanisms of photodynamic therapy
US8180444B2 (en) Enhanced PhotoDynamic Therapy with immune system assist
WO2002096365A2 (en) Method for improving treatment selectivity and efficacy using intravascular photodynamic therapy
JP2006514567A (ja) 発毛
Rovers et al. Significantly increased lesion size by using the near‐infrared photosensitizer 5, 10, 15, 20‐tetrakis (m‐hydroxyphenyl) bacteriochlorin in interstitial photodynamic therapy of normal rat liver tissue
Harvey et al. Killing tumor cells: the effect of photodynamic therapy using mono-L-aspartyl chlorine and NS-398
Hampton et al. Photodynamic therapy: a new modality for the treatment of cancer
HK1025059B (en) Method of activating photosensitive agents

Legal Events

Date Code Title Description
MK1K Patent expired